Private equity giant KKR & Co is set to take a 20% stake in Australian-made cancer and cardiac care company, GenesisCare. The investment is being made through KKR’s Core Investments strategy, which has a long-term mandate . The move signifies a return to GenesisCare for KKR, who purchased a 45% stake in 2012, before selling to China Resources Group and Macquarie Capital in 2016. Genesis Care Pty Ltd owns and operates healthcare centers that provide radiation oncology, cardiology, and sleep disorders treatment services in Australia, United Kingdom, and Spain. KKR’s investment provides new funding for GenesisCare's expansion plans, which include rolling out 35 new sites in Australia, Europe and also China. Commenting of the deal Ros Anderson said: “We are pleased to have worked with our long-standing client to once again take an ownership stake in this global healthcare provider.”